Professor John Manners-Bell BA (Hons) MSc AKC FCILT

Email : [email protected]

Tel : +44 (0)1666 519900

Prof John Manners-Bell is Chief Executive of Ti, Honorary Visiting Professor at the London Metropolitan University’s Guildhall Faculty of Business and Law and an adviser to the World Economic Forum. He has over 25 years’ experience working in and analysing the global logistics sector. John started his working life as an operations manager of a logistics company based in the UK. Prior to establishing Ti in 2002, he worked as an analyst in consultancies specialising in international trade, transport and logistics. He also spent a number of years as a manager of UPS, in a strategic marketing and communications role. John holds an MSc in Transport Planning and Management from University of Westminster and is an Associate of King’s College London where he studied Classics and Theology. He is a Fellow of the UK Chartered Institute of Logistics and Transport and former Chair of the Supply Chain and Logistics Global Advisory Council of the World Economic Forum.  He has also advised the European Commission Directorate-General for Energy and Transport. He has written three books on the industry – ‘Global Logistics Strategies: Delivering the Goods’, ‘Supply Chain Risk: Understanding Emerging Threats to Global Supply Chains’ and ‘Logistics and Supply Chains in Emerging Markets’. His second book, ‘Supply Chain Risk’ won the Mention Speciale ACA-Bruel Prize for supply chain literature in 2014.

 

Contact John: [email protected]

GSCi

The world's largest collection of global supply chain intelligence

  • quickly and easily search and gain invaluable insight into the logistics industry
  • Empower everyone from business development executives to CEO level
  • Enhance the role of the market research department

Recent briefs :

Pfizer’s dizzying growth has slowed in Q3 2022


Pfizer is the largest global pharmaceutical company by revenue. In 2021, Pfizer produced revenues of €78,460.52m, a 51% increase on its 2020 revenue of €40,199.44m. Pfizer and German biotechnology company BioNTech SE collaborated to jointly develop a COVID-19 vaccine using BioNTech’s messenger RNA (mRNA) vaccine program. The Covid-19 vaccine was the first to be approved …

How Nestlé is Greening the Supply Chain


Nestlé is using science, technology, and innovation to help it to meet the 2030 goal of zero environmental impact across its operations, and net zero greenhouse gas emissions by 2050. The company is developing many processes and tools that help it to estimate and lower its overall carbon footprint, for example, KitKat will become a carbon neutral brand by 2025. It was the first global chocolate brand to be made using 100% sustainably sourced cocoa.